Study Evaluating the Safety,Tolerability, PK and PD of SAM-531 in the Subjects With Mild to Moderate Alzheimer's Disease
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to assess whether SAM-531, an investigational drug, is
safe and well tolerated, compared with placebo (a medically inactive substance), in subjects
with mild to moderate Alzheimer's disease.